Skip to main content

Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001840574

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Verve Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of VERV: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders9692−4
Shares45.2M46.6M+1.49M (+3.3%)
Value$1.66B$1.06B−$598.7M (−36.0%)

New holders (19)

Institutions that held Verve Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to VERV in Q1 2022
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP369,765$8.44M0.33%
M28 Capital Management LP178,500$4.07M3.74%
Squarepoint Ops LLC29,382$670.0K0.00%
Two Sigma Investments, LP27,594$630.0K0.00%
Barclays PLC24,995$571.0K0.00%
Cubist Systematic Strategies, LLC24,466$558.0K0.00%
Tudor Investment Corp Et Al24,216$553.0K0.01%
Los Angeles Capital Management LLC16,685$381.0K0.00%
CIBC World Markets Inc.12,474$285.0K0.00%
Qube Research & Technologies Ltd12,155$277.0K0.00%
Erste Asset Management GmbH11,300$273.7K0.01%
E Fund Management Co., Ltd.9,282$212.0K0.01%
Westwood Holdings Group Inc.9,073$207.0K0.00%
Point72 Hong Kong Ltd5,253$120.0K0.01%
Amalgamated Bank4,398$100.0K0.00%
Amalgamated Financial Corp.4,398$100.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)2,919$67.0K0.00%
Penserra Capital Management LLC2,040$46.0K0.00%
High Net Worth Advisory Group LLC500$11.0K0.00%

Sold out (23)

Institutions that held Verve Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.